(Q33694914)

28 July 2017

1 reference

title

EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium (English)

1 reference

28 July 2017

4

Simard J

1 reference

28 July 2017

Labrie F

1

1 reference

28 July 2017

Labrie C

2

1 reference

28 July 2017

Bélanger A

3

1 reference

28 July 2017

Gauthier S

5

1 reference

28 July 2017

Luu-The V

6

1 reference

28 July 2017

Mérand Y

7

1 reference

28 July 2017

Giguere V

8

1 reference

28 July 2017

Candas B

9

1 reference

28 July 2017

Luo S

10

1 reference

28 July 2017

Martel C

11

1 reference

28 July 2017

Singh SM

12

1 reference

28 July 2017

Fournier M

13

1 reference

28 July 2017

Coquet A

14

1 reference

28 July 2017

Richard V

15

1 reference

28 July 2017

Charbonneau R

16

1 reference

28 July 2017

Charpenet G

17

1 reference

28 July 2017

Tremblay A

18

1 reference

28 July 2017

Tremblay G

19

1 reference

28 July 2017

Cusan L

20

1 reference

28 July 2017

Veilleux R

21

1 reference

28 July 2017

1 April 1999

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

28 July 2017

1 reference

28 July 2017

69

1 reference

28 July 2017

1-6

1 reference

28 July 2017

51-84

1 reference

28 July 2017

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

The future of new pure antiestrogens in clinical breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Control of aromatase in breast cancer cells and its importance for tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Fundamental research leading to improved endocrine therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

1 reference

7 January 2021

DHEA and peripheral androgen and estrogen formation: intracinology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Synthesis and biological activity of new halo-steroidal antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Biology and mode of action of pure antioestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Mechanisms of antihormone action

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

The pharmacology and clinical uses of tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Clinical significance of tamoxifen withdrawal response

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Response after withdrawal of tamoxifen and progestogens in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen as risk factor for carcinoma of corpus uteri

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen and endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen for breast cancer: associated endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Potential role of tamoxifen in prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Long-term tamoxifen adjuvant therapy in node-positive breast cancer: a metabolic and pilot clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

ICI 182,780, a new antioestrogen with clinical potential

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Studies on the activation of the oestrogen receptor bound to the anti-oestrogens 4-hydroxytamoxifen and ICI 164,384 by using three monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Long-term inhibitory effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Structural organization and expression of the mouse estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Sequence and expression of human estrogen receptor complementary DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

ER beta: identification and characterization of a novel human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Functional domains of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Characterization of the Amino-terminal Transcriptional Activation Function of the Human Estrogen Receptor in Animal and Yeast Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Nuclear receptor coactivators and corepressors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Dopaminergic and Ligand-Independent Activation of Steroid Hormone Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Steroid hormone receptors and their regulation by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Control of Hormone Receptor Levels and Growth of 7,12-Dimethylbenz(a)anthracene-Induced Mammary Tumors by Estrogens, Progesterone and Prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Differential effects of estrogen and antiestrogen on in vitro clonogenic growth of human breast cancers in soft agar.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Comparative studies on the effects of steroidal and nonsteroidal oestrogen antagonists on the proliferation of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen flare in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tumour stimulation by anti-oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Hormone-induced tumor flare

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of delta 5 adrenal steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Hormonal control of proliferation in the Ishikawa endometrial adenocarcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Cancer of the uterine corpus after hormonal treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted Triphenylethylenes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

A new derivative of triphenylethylene: effect on implantation and mode of action in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Determinants of bone density in normal women: risk factors for future osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Menopause and risk factors for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Menopause and coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Evaluating the benefits and risks of postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Estrogen replacement therapy: indications and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Antiestrogenic properties of raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Long-term estrogen replacement therapy prevents bone loss and fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effect of castration on hyperlipidemic, insulin resistant JCR:LA-corpulent rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effects of high-dose ethinyl estradiol on serum concentrations and hepatic secretion of the very-low-density lipoprotein, triacylglycerol, cholesterol, and apolipoprotein A-I in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Alterations of plasma HDL lipids and apolipoproteins in female rats treated with ethynyl estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Pharmacologically induced hypolipidemia. The ethinyl estradiol-treated rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Tamoxifen, serum lipoproteins and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Estrogen and estrogen-progestogen replacement: therapy and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Novel antioestrogens without partial agonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

11 beta-Amidoalkoxyphenyl estradiols, a new series of pure antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Steroidal and nonsteroidal oestrogen antagonists in breast cancer: basic and clinical appraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Phase II Evaluation of Lyl56758 in Metastatic Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900065-5

7 January 2021

10.1016/S0960-0760(99)00065-5

Identifiers

DOI

1 reference

28 July 2017

1 reference